EMV Capital (AIM:EMVC) has picked up key assets of Destiny Pharma, the collapsed antibiotic developer, in a deal that Panmure Liberum says highlights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback